Clinical trial
Open-label, Single-arm, Non-controlled Trial to Evaluate Safety and Tolerability of Treprostinil Sodium in Children Below the Age of 18 Years Diagnosed With Pulmonary Arterial Hypertension (PAH)
NCT06350032 is registered in ClinicalTrials.gov with AOP Orphan Pharmaceuticals AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label, Single-arm, Non-controlled Trial to Evaluate Safety and Tolerability of Treprostinil Sodium in Children Below the Age of 18 Years Diagnosed With Pulmonary Arterial Hypertension (PAH)
- Lead sponsor
- AOP Orphan Pharmaceuticals AG
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 31, 2024
- Completion date
- November 30, 2028
- Enrollment
- 20 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.